CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic.


Journal

Heart, lung & circulation
ISSN: 1444-2892
Titre abrégé: Heart Lung Circ
Pays: Australia
ID NLM: 100963739

Informations de publication

Date de publication:
Jul 2020
Historique:
pubmed: 1 7 2020
medline: 19 8 2020
entrez: 1 7 2020
Statut: ppublish

Résumé

A pandemic of Coronavirus-19 disease was declared by the World Health Organization on March 11, 2020. The pandemic is expected to place unprecedented demand on health service delivery. This position statement has been developed by the Cardiac Society of Australia and New Zealand to assist clinicians to continue to deliver rapid and safe evaluation of patients presenting with suspected acute cardiac syndrome at this time. The position statement complements, and should be read in conjunction with, the National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016: Section 2 'Assessment of Possible Cardiac Chest Pain'.

Identifiants

pubmed: 32601022
pii: S1443-9506(20)30144-X
doi: 10.1016/j.hlc.2020.05.003
pmc: PMC7241352
pii:
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

e105-e110

Informations de copyright

Copyright © 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). All rights reserved.

Références

Heart Lung Circ. 2020 Jun;29(6):e69-e77
pubmed: 32471696
Med J Aust. 2017 Aug 4;207(5):195-200
pubmed: 28987132
N Engl J Med. 2000 Apr 20;342(16):1163-70
pubmed: 10770981
Ann Intern Med. 2017 May 16;166(10):715-724
pubmed: 28418520
Med J Aust. 2017 Aug 4;207(5):201-205
pubmed: 28987133
J Am Coll Cardiol. 2019 Jul 23;74(3):271-282
pubmed: 31319909
JAMA. 2017 Nov 21;318(19):1913-1924
pubmed: 29127948
Clin Chem. 2018 May;64(5):820-829
pubmed: 29419380
Heart Lung Circ. 2016 Sep;25(9):895-951
pubmed: 27476580

Auteurs

William A Parsonage (WA)

Royal Brisbane & Women's Hospital, Brisbane, Qld, Australia. Electronic address: w.parsonage@mac.com.

Louise Cullen (L)

Royal Brisbane & Women's Hospital, Brisbane, Qld, Australia.

David Brieger (D)

Concord Hospital, Sydney, NSW, Australia.

Graham S Hillis (GS)

Royal Perth Hospital, Perth, WA, Australia.

Arthur Nasis (A)

Monash Heart, Melbourne, Vic, Australia.

Nathan Dwyer (N)

Royal Hobart Hospital, Hobart, Tas, Australia.

Sudhir Wahi (S)

Princess Alexandra Hospital, Brisbane, Qld, Australia.

Sidney Lo (S)

Liverpool Hospital, Greater Western Sydney, NSW, Australia.

Martin Than (M)

Christchurch Hospital, Christchurch, New Zealand.

Andrew Kerr (A)

Middlemore Hospital, Auckland, New Zealand.

Gerard Devlin (G)

Waikato Hospital, Wellington, New Zealand.

Derek K Chew (DK)

Flinders Medical Centre, Adelaide, SA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH